Efficient. Effective. Respected.

Discover why leading interventionalists offer mild® to treat Lumbar Spinal Stenosis (LSS).

What mild® Physicians are Saying

Clinically Significant Outcomes for mild®

Graphic - HCP - Mean improvement in function & pain with mild Procedure
Long-Term Efficacy

MiDAS ENCORE 2-Year, Level 1 Study: mild® provides clinically meaningful, statistically significant improvements in mobility, ODI, and pain reduction on the NPRS.

Graphic - HCP - Clinical outcomes for patients with comorbidities
Effective for Patients with Comorbidities

MiDAS ENCORE 2-Year, Level 1 Study: mild® is effective in treating patients with multiple stenosis types, including lateral and foraminal stenosis.

Graphic - HCP - Mild Procedure has safety profile equivalent to an ESI
Safety Profile Equivalent to an ESI

MiDAS ENCORE 2-Year, Level 1 Study: mild® has an equivalent safety profile to an ESI, but with lasting results. In this study, there were no statistically significant differences in the safety profile between study groups.

mild® is a minimally invasive procedure typically performed in an outpatient setting using local anesthetics and light sedation. The nature of the procedure carries that do not apply to receiving an epidural steroid injection.

Graphic - HCP - Mean Standing Time: 600% Improvement - Mean Walking Distance: Over 1,500% Improvement
Patients Stand 7x Longer & Walk 16x Farther

Cleveland Clinic 1-Year Study: Patients’ average standing time improved from 8 min. to 56 min. and average walking distance increased from 246 ft. to 3,956 ft.

Graphic - 5-Year Durability
Patients Avoid Back Surgery

Cleveland Clinic 5-Year Study: 88% of mild® patients avoided back surgery for at least 5 years while experiencing significant symptom relief.

85% Patient Satisfaction
Patient Satisfaction

MiDAS ENCORE 2-Year Study: Patients reported an 85% patient satisfaction rate with the mild® Procedure.

View the mild® Procedure’s Body of Evidence

Look for the Ligament, it’s a Common Problem

HLF contributes up to 85% of spinal canal narrowing.

Identifying mild® Candidates

Identify Neurogenic Claudication Symptoms
  • Presents as discomfort in back, legs or buttocks with ambulation that improves with flexion - often referred to as “shopping cart syndrome.”
Confirm Hypertrophic Ligamentum Flavum (HLF)
  • Review images to identify HLF ≥ 2.5 mm.
Effective for Patients with Comorbidities
  • Just 5% of MiDAS ENCORE patients presented with central canal stenosis only.

Expanding Minimally Invasive LSS Treatment Options

Several cross disciplinary leaders in the interventional spine community, representing many surgical and pain societies, have formed a consensus group to evaluate the current state of LSS diagnosis and treatment, and to make recommendations to guide clinical practice in this emerging area.

The Next Step to Providing Patients Lasting Results May Be mild®

Remove The Problem.
Leave Nothing Behind.

With new therapies emerging, you can now think differently about treating LSS patients. Move beyond palliative therapies and address a major root cause of LSS, without leaving any implants behind. If HLF is present, advance to mild® to provide patients long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results.

LSS treatment algorithm

mild® Procedural Benefits

Short Efficient Outpatient Procedure Icon
Efficient Outpatient Procedure
  • No general anesthesia, implants, stitches, steroids or opioids required
  • Can be performed through a single, tiny incision under still- and live-image fluoroscopic guidance, which allows streamlined access to multiple levels and sides, reducing non-treating time
Low Risk Profile Icon
Low Risk Profile
  • Clinically proven safety profile equivalent to an ESI
Removes the Problem Icon
Removes the Problem
  • mild® removes a major root cause of neurogenic claudication by debulking the hypertrophic ligamentum flavum, which reduces the compression of the nerves
No Implants Icon
Quick Recovery Time
  • Patients typically resume normal activity within 24 hours with no restrictions
Quick Recovery Time Icon
Doesn’t Burn Bridges
  • No implants and no major structural anatomy altered
  • No co-occurring or future treatment options eliminated

mild® Procedural Benefits

QUICK RECOVERY TIME EFFICIENT OUTPATIENT PROCEDURE LOW RISK PROFILE REMOVES THE PROBLEM DOESN’T BURN BRIDGES QUICK RECOVERY TIME Patients typically resume normal activity within 24 hours with no restrictions 8 EFFICIENT OUTPATIENT PROCEDURE No general anesthesia, implants, stitches, steroids or opioids required Can be performed through a single, tiny incision under still- and live-image fluoroscopic guidance, which allows streamlined access to multiple levels and sides, reducing non-treating time LOW RISK PROFILE Clinically proven safety profile equivalent to an ESI 1 REMOVES THE PROBLEM mild ® removes a major root cause of neurogenic claudication by debulking the hypertrophic ligamentum flavum, which reduces the compression of the nerves DOESN’T BURN BRIDGES No implants and no major structural anatomy altered 2 No co-occurring or future treatment options eliminated

Visualizing the mild® Procedure

Lumbar decompression performed through an incision smaller than the size of a baby aspirin (5.1 mm).

Watch the mild® Procedure

Strong Safety Profile

Graphic - HCP - Safety profile equivalent to an ESI
Safety Profile Equivalent to an ESI
  • Decompression performed posterior to the epidural space with no general anesthesia, implants, stitches, steroids or opioids required. Generally performed with local anesthetic and light sedation.
Graphic - Incision smaller than the size of a baby aspirin (5.1 mm)
Efficient Outpatient Procedure
  • Can be performed through a single, tiny incision under still-and live-image fluoroscopic guidance, which allows streamlined access to multiple levels and sides
  • Patients typically resume normal activity within 24 hours with no restrictions
Graphic - Maintains structural anatomy, full spine
Maintains Structural Anatomy
  • Does not significantly alter the structural anatomy of the spine or eliminate future treatment options

Complication Rate

Thousands of patients are treated annually with the mild procedure
  • Reported complication rate of <0.1%
  • Compatible for patients with existing risk factors

Training & Education

In collaboration with the nation’s leading mild® practitioners, we provide training and education to physicians and practices across the U.S.

Mastering the mild® Procedure- Training Objectives:

Healthcare professionals reviewing back x-ray

1

Identify and Treat the Right Patients
Patient undergoing mild procedure for Lumbar Spinal Stenosis

2

Establish Comfort and Clinical Efficiency
Vertos Mild Procedure Logo

3

Refine Your Treatment Algorithm

Familiarity with fluoroscopic imaging techniques and expertise in the epidural space are key qualification requirements for performing mild®.


For interventional pain fellows interested in learning more, please visit our mild360 page.

Request Training

Request Training

Body of Evidence: Two Level 1 Studies. Five-Year Durability.

Reimbursement

Vertos Medical makes it simple to set up claims, so you can get back to treating your patients.

mild® is nationally covered by all Medicare and Medicare Advantage plan types

Vertos can assist with setting up claims and address any questions you may have. As a general notice, Vertos provides procedure-specific information about codes that may be used for procedures that employ our technology and products. Reimbursement methods vary by payor and site of service.

As commercial insurance coverage for the mild® Procedure varies by payor policy, we encourage providers to contact non-Medicare payors to confirm coverage prior to performing the procedure. If you have questions or are interested in commercial policy advocacy, please contact our Market Access Team.

      Billing Guide

For Coding, Coverage and Reimbursement Support:

Phone

(855) 848-6453

Email

reimbursement@vertosmed.com

Payor and Policy Support:

Email

marketaccess@vertosmed.com

Payor Advocacy Interest Form

Link to Form

Resources

Quick access to tools and information about mild®

Resource Library

Learn more about the mild® Procedure through didactic lectures, discussions and a compendium of case reviews from other leading experts.

Access On-Demand Webcasts

Please see the Vertos Medical guide for simple claim set-up instructions and contact information.

Download Billing Guide

Frequently Asked Questions

Click here to view the “Minimally Invasive Lumbar Decompression: A Review of Indications, Techniques, Efficacy and Safety” and references for this chart.

Comparison chart of complications between various decompression procedures

 

All lumbar levels, including L5-S1, are treatable with mild®. The physician should decide which levels to treat based on symptom and imaging assessment.

mild® in the Spotlight: News & Events

The latest news stories, events, company news releases, and media coverage on mild®.

American Society of Pain & Neuroscience Annual Conference 2024

July 11-14, 2024

Celebrating over 100,000 mild® PATIENTS at ASPN 2024!

Dr. David Dickerson and other leading mild® providers captivated a packed room with their insights on how they elevated their practice with mild®. Attendees learned the latest clinical findings and proven strategies to expand patient access and build a thriving practice with mild®. mild® providers were also able to share success stories recorded live at our custom recording booth!

Learn more

The MOTION Study: Two-Year Results of a Prospective Multicenter Randomized Controlled Study of mild®

The Motion Study | Level 1 Data. 2-Year Objective, Real-World Outcomes. - Mobile and Blog Image
September 3, 2023

This study measures the impact of the mild® Procedure as a first-line therapy on patients otherwise receiving conventional medical management (CMM) for lumbar spinal stenosis (LSS) with neurogenic claudication (NC) secondary to hypertrophic ligamentum flavum. It demonstrated that the mild® Procedure, when combined with CMM, is superior in providing improved function and decreased pain when compared to CMM alone. These results provide support for early interventional treatment of symptomatic LSS with the mild® Procedure. 

Learn more 
© 2024 Vertos Medical, Inc. All Rights Reserved.